Correspondence 0001493152-23-021032 from Bone Biologics Corp (BBLG)
Bone Biologics Corp
Date: June 13, 2023 · CIK: 0001419554 · Accession: 0001493152-23-021032
AI Filing Summary & Sentiment
File numbers found in text: 333-271558
Show Raw Text
CORRESP
1
filename1.htm
June
13, 2023
VIA
EDGAR
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
DC 20549
Re:
Bone
Biologics Corp.
Registration
Statement on Form S-1 (File No. 333-271558)
Ladies
and Gentlemen:
In
connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the
“Act”), EF Hutton, Division of Benchmark Investments, LLC, as representative of the underwriters, hereby joins in the request
of the Company that the effective date of such registration statement be accelerated to 5:30 p.m. (New York time) on June 14, 2023, or
as soon thereafter practicable.
In
making this request, the undersigned acknowledges that the underwriters are aware of their obligations under the Act as they relate to
the public offering of securities pursuant to the registration statement.
[signature
page follows]
Very
truly yours,
EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC
By:
/s/
Sam Fleischman
Name:
Sam
Fleischman
Title:
Supervisory
Principal